At a glance
Our pivotal position in the rapidly evolving regenerative medicine field is supported by a group of leading investors. Through the significant funding we have raised and the continual development of our pipeline of novel tissue-specific cellular medicines, we are well positioned to push the frontiers of science and innovation in regenerative medicine.
Investor Enquiries
For investor enquiries please contact: